Pular para o conteúdo principal

How cells control nuclear size becomes clearer

Fission yeast cells are shown under the microscope. Wild type (A) compared to mutated with swollen nucleus (B). Credit: Kazunori Kumi
Over a century since scientists first observed that cells and their nucleus grow at a constant ratio to each other, we are now closer to finding out how.
The cell cycle, the process of cell growth and division that sees "daughter" cells enlarge before dividing again, includes the nucleus -- the cell's condensed genetic control center -- simultaneously dividing and enlarging hand-in-hand with their cell.
The mechanism involved in this in-tandem augmentation has proven one of the great-unanswered questions of cell biology; the bigger the cell the bigger the nucleus, but what controls this proportional enlargement?
Assistant Professor Kazunori Kume of Hiroshima University, through his latest research into yeast cells, has discovered that the hoarding of genetic materials (mRNA) and proteins by the nucleus causes it to bulk up. He further proposes that this swelling is enabled by controlling the transport of mRNA and proteins from the nucleus into the encompassing liquid cytoplasm, and the amount of nuclear membrane supplied via lipid synthesis.
As it is already known that the consistent size ratio between cells and nuclei deviates with age, and also due to cancer, it is hoped these new findings could assist our understanding of body degeneration and its prevention.
Yeast, a single celled organism, shares many characteristics and a size similar to cells found in humans and other eukaryotes.
This latest discovery saw Assistant Professor Kume, from HU's Research Center for Healthy Aging, carry out a comprehensive search of the fission yeast genome in the hope of finding illusive genes that determine nucleus size.
Knowing that of the 5000 genes found in fission yeast, 2000 are essential for cell growth, he looked at the other 3000 in the hope that some might be involved in controlling the size of the nucleus instead.
One-by-one each of these 3000 genes was removed in isolation and the resultant mutated yeast cell was observed under the microscope.
By recording the dimensions of each of the resultant cells and their nucleus, he was able to calculate a cell-to-nucleus ratio -- a painstaking process that paid off. He found 14 genes whose deletion lead to a greater cell-to-nucleus ratio than the usual 0.08, suggesting they were responsible for this ratio's maintenance.
Further investigation into these nuclei showed that the usual mechanisms required for transporting mRNA from inside the nucleus, where it is produced, to outside into the cell's cytoplasm, where it is required for protein production, was defective -- meaning the mRNA couldn't get out!
mRNA molecules contain genetic information for producing proteins and true to form, analysis of the larger mutated nuclei showed that they contained, not only a higher concentration of mRNA but also mRNA derived proteins, causing them to swell.
This nuclear swelling was also seen to be dependent on lipid production, which is required for nuclear membrane expansion. Interestingly the researchers found that even disruption of lipid production alone deregulated nuclear membrane growth, resulting in an increased nuclear size.
While this research finally shines a light on cell-to-nucleus ratio maintenance, Assistant Professor Kume admits there is still a long way to go before they can fully understand what is occurring:
"There are so many questions that now need answering, what triggers these membrane changes? Does nuclear expansion cause cancer or result from it? What causes these specific genes to mutate? This research is just the first step into the unknown, It means I now have leads to follow and more mysteries to solve!"
Postado por David Araripe

Comentários

Postagens mais visitadas deste blog

CONSERVAÇÃO DE ALIMENTOS E A EQUAÇÃO DE ARRHENIUS por Carlos Bravo Diaz, Universidade de Vigo, Espanha

Traduzido por Natanael F. França Rocha, Florianópolis, Brasil  A conservação de alimentos sempre foi uma das principais preocupações do ser humano. Conhecemos, já há bastante tempo, formas de armazenar cereais e também a utilização de azeite para evitar o contato do alimento com o oxigênio do ar e minimizar sua oxidação. Neste blog, podemos encontrar diversos ensaios sobre os métodos tradicionais de conservação de alimentos. Com o passar do tempo, os alimentos sofrem alterações que resultam em variações em diferentes parâmetros que vão definir sua "qualidade". Por exemplo, podem sofrer reações químicas (oxidação lipídica, Maillard, etc.) e bioquímicas (escurecimento enzimático, lipólise, etc.), microbianas (que podem ser úteis, por exemplo a fermentação, ou indesejáveis caso haja crescimento de agentes patogênicos) e por alterações físicas (coalescência, agregação, etc.). Vamos observar agora a tabela abaixo sobre a conservação de alimentos. Por que usamo...

Two new proteins connected to plant development discovered by scientists

The discovery in the model plant Arabidopsis of two new proteins, RICE1 and RICE2, could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, and ultimately to improve agricultural productivity, according to researchers at Texas A&M AgriLife Research. Credit: Graphic courtesy of Dr. Xiuren Zhang, Texas A&M AgriLife Research The discovery of two new proteins could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, thus improving agriculture productivity, according to researchers at Texas A&M AgriLife Research. The two proteins, named RICE1 and RICE2, are described in the May issue of the journal eLife, based on the work of Dr. Xiuren Zhang, AgriLife Research biochemist in College Station. Zhang explained that DNA contains all the information needed to build a body, and molecules of RNA take that how-to information to the sites in the cell where they can be used...

Fármaco brasileiro aprovado nos Estados Unidos

  Em fotomicrografia, um macho de Schistosoma mansoni, causador da esquistossomose CDC/G. Healy A agência que regula a produção de alimentos e medicamentos dos Estados Unidos, a FDA, concedeu o status de orphan drug para o fármaco imunomodulador P-Mapa, desenvolvido pela rede de pesquisa Farmabrasilis, para uso no tratamento de esquistossomose.  A concessão desse status é uma forma de o governo norte-americano incentivar o desenvolvimento de medicamentos para doenças com mercado restrito, com uma prevalência de até 200 mil pessoas nos Estados Unidos, embora em outros países possa ser maior. Globalmente, a esquistossomose é uma das principais doenças negligenciadas, que atinge cerca de 200 milhões de pessoas no mundo e cerca de 7 milhões no Brasil.  Entre outros benefícios, o status de orphan drug confere facilidades para a realização de ensaios clínicos, após os quais, se bem-sucedidos, o fármaco poderá ser registrado e distribuído nos Estados Unidos, no Brasil e em outro...